Paper37542151
CRISPR/sgRNA-directed synergistic activation mediator (SAM) as a therapeutic tool for Parkinson´s disease.
Narváez-Pérez LF and 5 others. Gene Ther, 2024. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. CRISPR/sgRNA-directed synergistic activation mediator (SAM) as a therapeutic tool for Parkinson´s disease. Papers, record 37542151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37542151
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- CRISPR/sgRNA-directed synergistic activation mediator (SAM) as a therapeutic tool for Parkinson´s disease.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Parkinson Disease | Major topic |
| Neurodegenerative Diseases | Major topic |
| Rats | |
| Animals | |
| RNA, Guide, CRISPR-Cas Systems | |
| Oxidopamine | |
| Rats, Sprague-Dawley | |
| Clustered Regularly Interspaced Short Palindromic Repeats | |
| Dopamine | |
| Corpus Striatum | |
| Tyrosine 3-Monooxygenase | |
| Substantia Nigra |
Source PubMed
References72
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29710735 | Gene Therapy for Parkinson's Disease, An Update. | J Parkinsons Dis | 2018 | https://conductscience.org/library/papers/29710735 | PubMed |
| 2 | 23287972 | Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review. | J Neurol | 2013 | https://conductscience.org/library/papers/23287972 | PubMed |
| 3 | 10877925 | Real-time dynamics of dopamine released from neuronal transplants in experimental Parkinson's disease. | Exp Neurol | 2000 | https://conductscience.org/library/papers/10877925 | PubMed |
| 4 | 23238327 | D3 dopamine receptors interact with dopamine D1 but not D4 receptors in the GABAergic terminals of the SNr of the rat. | Neuropharmacology | 2013 | https://conductscience.org/library/papers/23238327 | PubMed |
| 5 | 8469306 | Dopamine-rich grafts in the neostriatum and/or nucleus accumbens: effects on drug-induced behaviours and skilled paw-reaching. | Neuroscience | 1993 | https://conductscience.org/library/papers/8469306 | PubMed |
| 6 | 8281440 | Decarboxylation of L-dopa by cultured mouse astrocytes. | Brain Res | 1993 | https://conductscience.org/library/papers/8281440 | PubMed |
| 7 | 26090233 | Striatal Injury with 6-OHDA Transiently Increases Cerebrospinal GFAP and S100B. | Neural Plast | 2015 | https://conductscience.org/library/papers/26090233 | PubMed |
| 8 | 4332693 | Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. | Acta Physiol Scand Suppl | 1971 | https://conductscience.org/library/papers/4332693 | PubMed |
| 9 | 29257290 | Time-course behavioral features are correlated with Parkinson's disease‑associated pathology in a 6-hydroxydopamine hemiparkinsonian rat model. | Mol Med Rep | 2018 | https://conductscience.org/library/papers/29257290 | PubMed |
| 10 | 31963575 | Regulation of BDNF-TrkB Signaling and Potential Therapeutic Strategies for Parkinson's Disease. | J Clin Med | 2020 | https://conductscience.org/library/papers/31963575 | PubMed |
| 11 | 9808338 | Glial cell line-derived neurotrophic factor (GDNF): a drug candidate for the treatment of Parkinson's disease. | J Neurol | 1998 | https://conductscience.org/library/papers/9808338 | PubMed |
| 12 | 32848096 | CRISPR-engineered human brown-like adipocytes prevent diet-induced obesity and ameliorate metabolic syndrome in mice. | Sci Transl Med | 2020 | https://conductscience.org/library/papers/32848096 | PubMed |
| 13 | 30474172 | Immune system responses in Parkinson's disease: Early and dynamic. | Eur J Neurosci | 2019 | https://conductscience.org/library/papers/30474172 | PubMed |
| 14 | 27934604 | Generation of induced pluripotent stem cells (iPSCs) stably expressing CRISPR-based synergistic activation mediator (SAM). | Stem Cell Res | 2016 | https://conductscience.org/library/papers/27934604 | PubMed |
| 15 | 25188235 | Striatal astrocytes act as a reservoir for L-DOPA. | PLoS One | 2014 | https://conductscience.org/library/papers/25188235 | PubMed |
| 16 | 26735016 | High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. | Nature | 2016 | https://conductscience.org/library/papers/26735016 | PubMed |
| 17 | 29227284 | Cografting astrocytes improves cell therapeutic outcomes in a Parkinson's disease model. | J Clin Invest | 2018 | https://conductscience.org/library/papers/29227284 | PubMed |
| 18 | 22033507 | Postmortem studies in Parkinson's disease. | Dialogues Clin Neurosci | 2004 | https://conductscience.org/library/papers/22033507 | PubMed |
| 19 | 25494202 | Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. | Nature | 2015 | https://conductscience.org/library/papers/25494202 | PubMed |
| 20 | 8721156 | Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behaviour and striatal Fos expression. | Exp Brain Res | 1996 | https://conductscience.org/library/papers/8721156 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42862306 | CRISPR/Cas9-based nanodelivery systems for precision gene editing in neuroinflammation. | Inflamm Res | 2026 | https://conductscience.org/library/papers/42862306 | PubMed |
| 42563249 | Injectable Supramolecular Hydrogel Encapsulating CRISPR-Engineered MSCs Drives Synergistic Neuroprotection and Functional Recovery After Traumatic Brain Injury. | Adv Healthc Mater | 2026 | https://conductscience.org/library/papers/42563249 | PubMed |
| 42268478 | CRISPR-Based Gene Therapy for Brain Disease. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42268478 | PubMed |
| 41877893 | CRISPR-based Transcriptional Regulation: Technologies, Applications, and Future Directions. | DNA (Basel) | 2025 | https://conductscience.org/library/papers/41877893 | PubMed |
| 41674784 | CRISPR-Cas technologies in neurodegenerative disorders: mechanistic insights, therapeutic potential, and translational challenges. | Front Neurol | 2025 | https://conductscience.org/library/papers/41674784 | PubMed |
| 40759894 | Histone lactylation regulates DOCK4 to control heat nociception and supports Dynein-mediated Nav1.7 trafficking. | Nat Commun | 2025 | https://conductscience.org/library/papers/40759894 | PubMed |
| 40406119 | Astrocyte-mediated inflammatory responses in traumatic brain injury: mechanisms and potential interventions. | Front Immunol | 2025 | https://conductscience.org/library/papers/40406119 | PubMed |
| 40362507 | From Synaptic Plasticity to Neurodegeneration: BDNF as a Transformative Target in Medicine. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40362507 | PubMed |
| 39949490 | CRISPR-dCas9 Activation of TSG-6 in MSCs Modulates the Cargo of MSC-Derived Extracellular Vesicles and Attenuates Inflammatory Responses in Human Intervertebral Disc Cells In Vitro. | Cell Mol Bioeng | 2025 | https://conductscience.org/library/papers/39949490 | PubMed |
| 39726634 | Advances in CRISPR-Cas technology and its applications: revolutionising precision medicine. | Front Genome Ed | 2024 | https://conductscience.org/library/papers/39726634 | PubMed |
| 39684197 | Advances and Challenges in Gene Therapy for Neurodegenerative Diseases: A Systematic Review. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39684197 | PubMed |
| 39596436 | Gene Therapy for Parkinson's Disease Using Midbrain Developmental Genes to Regulate Dopaminergic Neuronal Maintenance. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39596436 | PubMed |
| 39175618 | Assessment of CRISPRa-mediated gdnf overexpression in an In vitro Parkinson's disease model. | Front Bioeng Biotechnol | 2024 | https://conductscience.org/library/papers/39175618 | PubMed |
| 38180686 | Understanding current experimental models of glioblastoma-brain microenvironment interactions. | J Neurooncol | 2024 | https://conductscience.org/library/papers/38180686 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| DDC | 1644 | PubTator's text mining | https://conductscience.org/library/genes/1644 | NCBI Gene |
| LAT | 27040 | PubTator's text mining | https://conductscience.org/library/genes/27040 | NCBI Gene |
| SLC38A7 | 55238 | PubTator's text mining | https://conductscience.org/library/genes/55238 | NCBI Gene |
| SLC6A3 | 6531 | PubTator's text mining | https://conductscience.org/library/genes/6531 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37542151
GET https://conductscience.org/api/papers/v1/37542151/references?page=2